-
1
-
-
0030213196
-
Value relevance of nonfinancial information: Thewireless communications industry
-
August-December
-
Amir, E. and B. Lev (1996), 'Value Relevance of Nonfinancial Information: TheWireless Communications Industry', Journal of Accounting & Economics, Vol. 22 (August-December), pp. 3-30.
-
(1996)
Journal of Accounting & Economics
, vol.22
, pp. 3-30
-
-
Amir, E.1
Lev, B.2
-
2
-
-
54649084681
-
Brand values and capital market valuation
-
Barth, M.E., B. Clement, G. Foster and R. Kasznik (1998), 'Brand Values and Capital Market Valuation', Review of Accounting Studies, Vol. 3, Nos. 1-2.
-
(1998)
Review of Accounting Studies
, vol.3
, Issue.1-2
-
-
Barth, M.E.1
Clement, B.2
Foster, G.3
Kasznik, R.4
-
4
-
-
84990378574
-
Using non-financial information to predict financial performance: The case of the U.S. Airline industry
-
Behn, B.K. and R.A. Riley Jr. (1999), 'Using Non-financial Information to Predict Financial Performance: The Case of the U.S. Airline Industry', Journal of Accounting, Auditing, and Finance, Vol. 14 (Winter), pp. 29-56.
-
(1999)
Journal of Accounting, Auditing, and Finance
, vol.14
, Issue.WINTER
, pp. 29-56
-
-
Behn, B.K.1
Riley Jr., R.A.2
-
5
-
-
0003713797
-
-
Wiley, New York
-
Belsley, D., E. Kuh and R. Welsch (1980), Regression Diagnostics, Identifying Influential Data and Sources of Collinearity (Wiley, New York).
-
(1980)
Regression Diagnostics, Identifying Influential Data and Sources of Collinearity
-
-
Belsley, D.1
Kuh, E.2
Welsch, R.3
-
8
-
-
0003077926
-
Science & technology as predictors of stock performance
-
Deng, Z., B. Lev and F. Narin (1999), 'Science & Technology as Predictors of Stock Performance', Financial Analysts Journal, Vol. 55, pp. 20-32.
-
(1999)
Financial Analysts Journal
, vol.55
, pp. 20-32
-
-
Deng, Z.1
Lev, B.2
Narin, F.3
-
9
-
-
0025868362
-
Cost of innovation in the pharmaceutical industry
-
DiMasi, J.A., R.W. Hansen, H.G. Grabowski and L. Lasagna (1991), 'Cost of Innovation in the Pharmaceutical Industry', Journal of Health Economics, Vol. 10, pp. 107-42.
-
(1991)
Journal of Health Economics
, vol.10
, pp. 107-142
-
-
DiMasi, J.A.1
Hansen, R.W.2
Grabowski, H.G.3
Lasagna, L.4
-
10
-
-
21844487341
-
Do important drugs reach the market sooner?
-
Dranove, D. and D. Meltzer (1994), 'Do Important Drugs Reach the Market Sooner?' Rand Journal of Economics, Vol. 25 (Autumn), pp. 402-23.
-
(1994)
Rand Journal of Economics
, vol.25
, Issue.AUTUMN
, pp. 402-423
-
-
Dranove, D.1
Meltzer, D.2
-
11
-
-
77951518317
-
Drug development status in the evaluation of research and development costs
-
The Usefulness of Biotechnology Firms
-
Ely, K., P. Simko and L.G. Thomas (2002), 'The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs', Working Paper (Georgia Institute of Technology).
-
(2002)
Working Paper (Georgia Institute of Technology)
-
-
Ely, K.1
Simko, P.2
Thomas, L.G.3
-
12
-
-
0011314731
-
Accounting for research and development costs
-
Financial Accounting Standards Board (FASB
-
Financial Accounting Standards Board (FASB) (1974), 'Accounting for Research and Development Costs', Statement of Financial Accounting Standards No. 2.
-
(1974)
Statement of Financial Accounting Standards No. 2
-
-
-
13
-
-
58149210589
-
The information content of losses
-
Hayn, C. (1995), 'The Information Content of Losses', Journal of Accounting and Economics, Vol. 20, pp. 125-53.
-
(1995)
Journal of Accounting and Economics
, vol.20
, pp. 125-153
-
-
Hayn, C.1
-
14
-
-
84885627663
-
Intangible capital aspects of advertising and R&D expenditures
-
June
-
Hirschey, M. (1982), 'Intangible Capital Aspects of Advertising and R&D Expenditures', The Journal of Industrial Economics (June), pp. 375-90.
-
(1982)
Journal of Industrial Economics
, pp. 375-390
-
-
Hirschey, M.1
-
15
-
-
0001753445
-
Amortization policy for advertising and research and development expenditures
-
(Spring)
-
- and J.J. Weygandt (1985), 'Amortization Policy for Advertising and Research and Development Expenditures', Journal of Accounting Research (Spring), pp. 326-35.
-
(1985)
Journal of Accounting Research
, pp. 326-335
-
-
Weygandt, J.J.1
-
16
-
-
0042253188
-
Value relevance of nonfinancial information: The case of patent data
-
-, V.J. Richardson and S. Scholz (2001), 'Value Relevance of Nonfinancial Information: The Case of Patent Data', Review of Quantitative Finance and Accounting, Vol. 17 (November), pp. 223-35.
-
(2001)
Review of Quantitative Finance and Accounting
, vol.17
, Issue.NOVEMBER
, pp. 223-235
-
-
Richardson, V.J.1
Scholz, S.2
-
17
-
-
0030079993
-
The capitalization, amortization, and value-relevance of R&D
-
Lev, B. and T. Sougiannis (1996), 'The Capitalization, Amortization, and Value-relevance of R&D', Journal of Accounting and Economics, Vol. 21, pp. 107-38.
-
(1996)
Journal of Accounting and Economics
, vol.21
, pp. 107-138
-
-
Lev, B.1
Sougiannis, T.2
-
18
-
-
84984180909
-
Earnings, book values, and dividends in equity valuation
-
Ohlson, J.A. (1995), 'Earnings, Book Values, and Dividends in Equity Valuation', Contemporary Accounting Research, Vol. 11 (Spring), pp. 661-87.
-
(1995)
Contemporary Accounting Research
, vol.11
, Issue.SPRING
, pp. 661-687
-
-
Ohlson, J.A.1
-
19
-
-
6844253629
-
-
(available at) September 8
-
Pharmaceutical Researchers and Manufacturers Association (PhRMA) (1997), 'Industry Profile' (available at http://www.pharma.org/facts/industry/index. html) (September 8).
-
(1997)
Industry Profile
-
-
-
20
-
-
0344609831
-
-
available at, February 9
-
- (2002), 'Industry Profile' (available at http://www.phrma.org/ publications/profile01/chapter2.phtml) (February 9).
-
(2002)
Industry Profile
-
-
-
22
-
-
77951616773
-
Value relevance of accounting data: An investigation of the economic and accounting contexts in the pharmaceutical industry
-
Shores, D. and R.M. Bowen (2002), 'Value Relevance of Accounting Data: An Investigation of the Economic and Accounting Contexts in the Pharmaceutical Industry', Working Paper (University of Washington).
-
(2002)
Working Paper, University of Washington
-
-
Shores, D.1
Bowen, R.M.2
-
23
-
-
0002111199
-
The accounting based valuation of corporate R&D
-
Sougiannis, T. (1994), 'The Accounting Based Valuation of Corporate R&D', The Accounting Review, Vol. 69, pp. 44-68.
-
(1994)
The Accounting Review
, vol.69
, pp. 44-68
-
-
Sougiannis, T.1
-
25
-
-
0002385715
-
Pharmaceuticals: Redesigning R&D
-
Thayer, A.M. (1998), 'Pharmaceuticals: Redesigning R&D', Chemical & Engineering News, Vol. 76 (February), pp. 25-27.
-
(1998)
Chemical & Engineering News
, vol.76
, Issue.FEBRUARY
, pp. 25-27
-
-
Thayer, A.M.1
-
26
-
-
77951522459
-
Biotech and pharmaceuticals
-
Thuermer, K.E. (1998), 'Biotech and Pharmaceuticals', World Trade, Vol. 11 (March), pp. 52-53.
-
(1998)
World Trade
, vol.11
, Issue.MARCH
, pp. 52-53
-
-
Thuermer, K.E.1
-
27
-
-
77951558481
-
The impact of federally funded basic research on industrial innovation: Evidence from the pharmaceutical industry
-
Toole, A.A. (1997), 'The Impact of Federally Funded Basic Research on Industrial Innovation: Evidence from the Pharmaceutical Industry', Working Paper (Laurits R. Christensen Associates).
-
(1997)
Working Paper (Laurits R. Christensen Associates)
-
-
Toole, A.A.1
-
29
-
-
0000095552
-
A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
-
White, H. (1980), 'A Heteroskedasticity-consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity', Econometrica, Vol. 48, pp. 817-38.
-
(1980)
Econometrica
, vol.48
, pp. 817-838
-
-
White, H.1
|